When was Alere founded?

Alere was founded in 1991 and raised its 1st funding round 9 years after it was founded.

Where is Alere located?

Alere is headquartered in Waltham, United States.

How many employees does Alere have?

As of May 31, 2026, the latest employee count at Alere is 1758.

Is Alere a funded company?

Alere is a funded company, having raised a total of $616M across 26 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on 2000.

When was the latest funding round of Alere?

Alere's latest funding was a $***** Conventional Debt round on May 28, 2013, with participation from 0 investor.

What is the annual revenue of Alere?

Annual revenue of Alere is $2.36B as on Dec 31, 2016.

Where does Alere rank among its competitors?

Alere ranks 4th amongst 590 active competitors, of which 66 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was AvoMD, which secured $10M in Mar, 2026.

Who are the top competitors of Alere?

Alere's top competitors include Viz.ai, AvoMD and Arine. Among them, AvoMD secured the most recent funding round in March, 2026.

Alere - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of small rapid diagnostic devices for infectious diseases. It provides diagnostics and health management solutions. The company’s products and services are focused on infectious disease, cardiology, oncology, drugs of abuse, and women’s health. Its brands range from over-the-counter tests to lab-based diagnostics to integrated home monitoring solutions.

Website: alere.com
Part Of

Key Metrics

Founded Year

1991

Location

Waltham, United States

Stage

Public

Total Funding

$616M in 26 rounds

Latest Funding Round

Conventional Debt, May 28, 2013, $*****

Investors

YFM Equity Partners & 19 more

Ranked

4^th among 590 active competitors

Annual Revenue

$2.36B as on Dec 31, 2016

Employee Count

1,758 as on May 31, 2026

Investment & Acquisitions

US Diagnostics & 11 more

Similar Companies

AvoMD & 231 more

Exit Details

Public

View Alere's full profile

Alere is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ALERE INC. CIN: 1145460 , United States, Active	May 10, 2001	$2.36B (As on Dec 31, 2016)	7011 (As on Dec 31, 2022)	-

Alere got listed on Mar 12, 2018.

Click here to take a look at Alere's IPO in detail

Alere has raised a total funding of $616M over 26 rounds. Its first funding round was on 2000. Alere has 20 institutional investors.

Here is the list of recent funding rounds of Alere:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 28, 2013	2757520	Conventional Debt	5901552	2720427	8130718	3640921
Feb 2013	3454617	Grant (prize money)	3720727	2787242	6882574	Gates
Feb 2013	6924718	Conventional Debt	3766061	6950439	5020522	Gates

Access funding benchmarks and valuations. Sign up today!

View details of Alere's funding rounds and investors

The founders of Alere is Ron Zwanziger.

Here are the details of Alere's key team members:

Ron Zwanziger: Founder of Alere.

View details of Alere's Founder profiles and Board Members

Alere's employee count trend

Alere has 1,758 employees as of May 26. Here is Alere's employee count trend over the years:

Uncover Alere's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alere include Viz.ai, AvoMD and Arine. Here is the list of Top 10 competitors of Alere, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, DHVC & 16 others	69/100
2nd	AvoMD 2020, New York City (United States), Series A	Provider of a clinical decision support solution for healthcare professionals	$21.1M	Noro-Moseley Partners, AlleyCorp & 3 others	69/100
3rd	Arine 2017, San Francisco (United States), Series C	Medication management solution for healthcare professionals	$95M	111 West Capital, Town Hall Ventures & 10 others	64/100
4th	Alere 1991, Waltham (United States), Public	Developer of small rapid diagnostic devices for infectious diseases	$616M	ValueAct Capital, IVP & 18 others	64/100
5th	Pathway 2020, Montreal (Canada), Acquired	Provider of guidance tools for healthcare providers	$6.29M	VERGE, Yamaha Motor Ventures & 6 others	62/100
6th	Infervision 2016, Beijing (China), Series D	AI-based medical imaging and clinical diagnosis solutions	$213M	Goldman Sachs Investment Partners, Goldman Sachs Asset Management ... & 19 others	62/100
7th	Dawn Health 2016, Copenhagen (Denmark), Series C	Developer of software as a medical device and digital therapeutics	$67M	Chr. Augustinus Factories, Vaekstfonden & 5 others	61/100
8th	Grand Rounds 2011, San Francisco (United States), Series D	Provider of virtual care, navigation, and support for healthcare needs	$230M	BlackRock, The Carlyle Group & 4 others	59/100
9th	Airdoc 2015, Beijing (China), Public	Offers decision support solutions	-	Lilly Asia Ventures, Orbimed & 7 others	56/100
10th	Theranos 2003, Palo Alto (United States), Deadpooled	Digital tool for early detection and prevention of disease	$1.31B	Black Diamond Ventures, Harmony Venture Partners ... & 9 others	55/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Alere's competitors? Click here to see the top ones

Alere has made 1 investments in companies including PathCare Labs. Alere has also acquired 11 companies including US Diagnostics and Biosite.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 16, 2015	Acquisition	US Diagnostics	1999	Huntsville (United States)
Aug 11, 2013	Acquisition	Biosite	1988	San Diego (United States)
Feb 06, 2013	Acquisition	Standard Diagnostic	1999	Suwon-si (South Korea)